Advertisement

Topics

Seasonal Influenza Vaccines US Drug Forecast and Market Analysis to 2025 [Updated: 01112016] Prices from USD $4995

21:33 EST 25 Feb 2017 | BioPortfolio Reports

Seasonal Influenza Vaccines US Drug Forecast and Market Analysis to 2025

Summary

Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection's rapid onset and potential for high morbidity and mortality, particularly in highrisk patient populations such as the elderly and young children, make prompt and effective treatment with antiviral medication very difficult. For these reasons, prophylactic vaccination is the preferred intervention for seasonal influenza.

The US will experience solid growth in seasonal influenza vaccine sales during the forecast period, and this growth will be driven by a significant shift in the market share distribution of the different vaccine types. The US market will experience the largest nominal change of any country in the 7MM.

*This is an ondemand report and will be delivered within 24 hrs. excluding weekends of the purchase.

Scope

Overview of Seasonal Influenza Vaccines including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in the US including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in the US from 20152025.
Analysis of the impact of key events as well the drivers and restraints affecting the US Seasonal Influenza Vaccines market.

Reasons to buy

Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of the competition by understanding the changing competitive landscape for Seasonal Influenza Vaccines.
Effectively plan your MA and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and indepth analysis of drug performance
Obtain sales forecast for drugs from 20152025 in the US.

Original Article: Seasonal Influenza Vaccines US Drug Forecast and Market Analysis to 2025 [Updated: 01112016] Prices from USD $4995

NEXT ARTICLE

More From BioPortfolio on "Seasonal Influenza Vaccines US Drug Forecast and Market Analysis to 2025 [Updated: 01112016] Prices from USD $4995"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Swine Flu - H1N1 influenza - H7N9
Swine flu is the common name given to a relatively new strain of influenza (flu) that caused a flu pandemic in 2009-2010. It is also referred to as H1N1 influenza (because it is the H1N1 strain of virus). The H1N1 flu virus will be one of the main vi...